Pancreatic Cancer Research

ResearcherNanfang HospitalActive in the last 2 years

Wang Xiao

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-3673-4044.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 1, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. From Pyroptosis Heterogeneity to an Interpretable Prognostic Signature for Risk Stratification and Therapy Insights in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/biomedicines14040892↗
  2. Roles and Clinical Significances of ATF6, EMC6, and APAF1 in Prognosis of Pancreatic Cancer. First author DOI 10.3389/fgene.2021.730847↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Yixiong Lin · 1 shared paper, 2026
  2. Xiangsen Zou · 1 shared paper, 2026
  3. Peng Shen · 1 shared paper, 2021

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.